UBC faculty of medicine’s Dr. Robert Brunham and Dr. Natalie Strynadka, together with the faculty of science’s Steven Plotkin—along with a team of commercial and academic collaborators—are one step closer to achieving this thanks to a $1.8 million grant from the Digital Technology Supercluster COVID-19 Program, which aims to find solutions to urgent health care needs across Canada arising from…
Read More
If there has been a silver lining behind the otherwise menacing COVID-19 pandemic clouds for any sector of B.C.’s economy, it has been life sciences. Vancouver biotech and medical device companies have recently received government funding, inked partnerships with big pharmaceutical companies and gained quick regulatory approvals to move their platforms and discoveries to the front of the clinical trial…
Read More
In 2017, University of British Columbia botanist Lacey Samuels applied for her first permit from Health Canada to study cannabis. It was a complex process–even the smallest detail, like the size of frames and type of lock used on her lab doors had to be verified for security. After legalization of cannabis in Canada in 2018, scientists like Samuels expected…
Read More
Canada’s three federal research granting agencies—the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Social Sciences and Humanities Research Council (SSHRC)—recognize the vital role that highly qualified talent plays in the research enterprise and the need to sustain the talent pipeline during the major disruptions caused by the COVID-19 pandemic.…
Read More
The authors found that there was increased release of IL-1α and its family member IL-1β during the early stages of differentiation of airway epithelium from asthmatic patients compared to healthy individuals. They found that IL-1α/β induce airway fibroblasts to release pro-inflammatory cytokines that are known to be vital for allergic sensitization, smooth muscle cell-hypercontractility and airway hyperresponsiveness, as well as increased influx of eosinophils and TH2-driven inflammation in asthma.
Read More
Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has received, on June 3rd, 2020, clearance from the U.S. FDA for its recently submitted Investigational New Drug (IND) application for its planned multinational Phase 2b/3 study of its re-purposed drug NP-120 (Ifenprodil) as a potential therapeutic…
Read More
Public health authorities around the world are facing a significant challenge: ensuring a large enough supply of reagents to scale-up diagnostic testing for COVID-19. Researchers at UBC, Canada’s Michael Smith Genome Sciences Centre at BC Cancer (GSC) and the BC Centre for Disease Control (BCCDC) are working to develop new non-proprietary reagents to support testing in British Columbia. UBC geneticist…
Read More
Collaborative and interdisciplinary research is integral to scientific advancement. Too often, silos form around avenues of inquiry (and sometimes entire fields of study) limiting exposure to bright and enthusiastic minds who are ready to innovate and make a difference. It’s no small leap to see this as scientific advancement shooting itself in the foot. This is why the SBME was…
Read More
Cardiac complications and arrhythmias, which include fast, slow and irregular heartbeats, are major causes of death in patients with diabetes-related hyperglycemia. The arrhythmias are a consequence of high blood sugar levels called hyperglycemia, which radically affects the normal function of proteins in the heart. SFU researchers Peter Ruben, Mohamed Fouda and Reza Ghovanloo have new evidence that Cannabidiol (CBD), the…
Read More